000 -LEADER |
fixed length control field |
00633nam#a2200205#a#4500 |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20191030093016.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
181025 2007 pau eng |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9780443101076 |
041 ## - Language |
Language code of text/sound track or separate title |
eng |
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
Classification number |
615.19 |
Item number |
A924 |
Edition number |
23 |
245 00 - IMMEDIATE SOURCE OF ACQUISITION NOTE |
Title |
Aulton's pharmaceutics : |
Remainder of title |
the design and manufacture of medicine / |
Statement of responsibility, etc |
edited by Michael E. Aulton. |
250 ## - EDITION STATEMENT |
Edition statement |
3rd ed. |
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
Place of publication, distribution, etc |
Philadelphia, PA : |
Name of publisher, distributor, etc |
Churchill Livingstone, |
Date of publication, distribution, etc |
2007. |
300 ## - PHYSICAL DESCRIPTION |
Extent |
717 p. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Pharmacology |
9 (RLIN) |
15902 |
|
Topical term or geographic name as entry element |
Drugs |
General subdivision |
Design |
|
Topical term or geographic name as entry element |
Drugs |
General subdivision |
Dosage forms |
9 (RLIN) |
34924 |
700 10 - ADDED ENTRY--PERSONAL NAME |
Personal name |
Aulton, Michael E. |
Relator term |
editor |
9 (RLIN) |
18779 |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Source of classification or shelving scheme |
|
Item type |
Book |